| Indicators | Browse All

Dermata Therapeutics, Inc. (DRMAW)

San Diego, United States | NasdaqCM
0.00 USD 0.00 (-50.000%) ⇩ (Aug. 17, 2026, 11:53 a.m. EDT)

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 10:43 a.m. EDT

The security is effectively worthless and devoid of investment thesis. The price has collapsed to zero, trading at a fraction of its book value, while the company burns through significant cash reserves with negative free cash flow and no analyst coverage. There is no price history to suggest any recovery potential, and the lack of dividends confirms the capital is being consumed rather than returned. This is a clear avoid.

None
Attribute Value
Beta 0.66
Website https://www.dermatarx.com

Info Dump

Attribute Value
Address1 3,525 Del Mar Heights Rd.
Address2 Suite 332
Ask 0.0
Ask Size 0
Beta 0.663
Bid 0.0
Bid Size 0
Book Value 2.34
City San Diego
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.0006
Current Ratio 2.813
Custom Price Alert Confidence HIGH
Day High 0.0011
Day Low 0.0005
Ebitda Margins 0.0
Eps Trailing Twelve Months -2.156
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Two Week High 0.0011
Fifty Two Week High Change -0.00049999997
Fifty Two Week High Change Percent -0.45454544
Fifty Two Week Low 0.0005
Fifty Two Week Low Change 0.000100000005
Fifty Two Week Low Change Percent 0.2
Fifty Two Week Range 5.0E-4 - 0.0011
Financial Currency USD
First Trade Date Milliseconds 1,784,295,000,000
Float Shares 3,169,006
Free Cashflow -5,110,870
Full Exchange Name NasdaqCM
Full Time Employees 9
Fullday Change -0.0006
Fullday Change Percent -50.0
Fullday Price 0.0006
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Industry
Industry Key
Ipo Expected Date 2,021-08-13
Language en-US
Long Business Summary Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Long Name Dermata Therapeutics, Inc.
Market us_market
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_283634456
Net Income To Common -8,368,646
Open 0.0229
Operating Cashflow -8,034,258
Operating Margins 0.0
Phone 858 800 2543
Previous Close 0.0012
Price Hint 4
Price To Book 0.00025641028
Profit Margins 0.0
Quick Ratio 2.407
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.0006
Regular Market Change Percent -50.0
Regular Market Day High 0.0011
Regular Market Day Low 0.0005
Regular Market Day Range 5.0E-4 - 0.0011
Regular Market Open 0.0229
Regular Market Previous Close 0.0012
Regular Market Price 0.0006
Regular Market Time 1,786,982,029
Regular Market Volume 146,059
Return On Assets -0.89884
Return On Equity -1.83886
Sand P52 Week Change 0.16207206
Sector
Sector Key
Short Name Dermata Therapeutics, Inc. Warrant
Source Interval 15
State CA
Symbol DRMAW
Total Cash 4,412,764
Total Cash Per Share 1.097
Total Debt 0
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -2.156
Trailing Peg Ratio None
Triggerable 1
Type Disp Equity
Volume 146,059
Website https://www.dermatarx.com
Zip 92,130